Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies
- PMID: 3971385
Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies
Abstract
Three monoclonal antibodies, raised against human milk fat globule membranes, have been applied to 194 primary human breast carcinomas. The detected antigenic sites were found to be heterogeneously distributed. A statistical association with estrogen receptor content and grade of anaplasia was found for two of the antigens, Mam 3a and Mam 3b. The presence of all three antigens was independent of menopausal status, age, primary lymph node metastases, and progesterone receptor status. Life table analysis showed a better survival for patients with tumors positive for Mam 3b. The effect of these variables on recurrence-free survival has been analyzed using a Cox regression model. It is found that the most important prognostic factors are the number of positive lymph nodes, the estrogen receptor content, and the menopausal status of the high-risk patients. The ability of a model based on these factors to predict recurrence is not significantly improved by including any of the three surface antigens.
Similar articles
-
Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.Virchows Arch A Pathol Anat Histopathol. 1986;409(4):497-505. doi: 10.1007/BF00705420. Virchows Arch A Pathol Anat Histopathol. 1986. PMID: 3016978
-
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.J Clin Oncol. 2006 Dec 20;24(36):5637-44. doi: 10.1200/JCO.2005.05.4155. Epub 2006 Nov 20. J Clin Oncol. 2006. PMID: 17116944
-
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.Anticancer Res. 2004 Jul-Aug;24(4):2391-400. Anticancer Res. 2004. PMID: 15330189
-
Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.Surg Gynecol Obstet. 1989 Jul;169(1):81-98. Surg Gynecol Obstet. 1989. PMID: 2662454 Review.
-
[Monoclonal antibodies in mammary carcinoma].Medicina (B Aires). 1988;48(3):311-20. Medicina (B Aires). 1988. PMID: 3073296 Review. Spanish. No abstract available.
Cited by
-
Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.Virchows Arch A Pathol Anat Histopathol. 1986;409(4):497-505. doi: 10.1007/BF00705420. Virchows Arch A Pathol Anat Histopathol. 1986. PMID: 3016978
-
Human tumor and normal tissue reactivity of the anti-(breast cancer) monoclonal antibody BA-Br-3 and its similarity to the anti-(epithelial membrane antigen) monoclonal antibody E29.Cancer Immunol Immunother. 1990;31(2):65-75. doi: 10.1007/BF01742368. Cancer Immunol Immunother. 1990. PMID: 2182192 Free PMC article.
-
Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.Br J Cancer. 1987 Sep;56(3):295-9. doi: 10.1038/bjc.1987.192. Br J Cancer. 1987. PMID: 3663477 Free PMC article.
-
Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature.Breast Cancer (Dove Med Press). 2011 Dec 20;3:161-73. doi: 10.2147/BCTT.S26833. eCollection 2011. Breast Cancer (Dove Med Press). 2011. PMID: 24367185 Free PMC article.
-
The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.Virchows Arch A Pathol Anat Histopathol. 1988;413(1):3-10. doi: 10.1007/BF00844275. Virchows Arch A Pathol Anat Histopathol. 1988. PMID: 2453970
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials